JP2024511057A5 - - Google Patents

Info

Publication number
JP2024511057A5
JP2024511057A5 JP2023557407A JP2023557407A JP2024511057A5 JP 2024511057 A5 JP2024511057 A5 JP 2024511057A5 JP 2023557407 A JP2023557407 A JP 2023557407A JP 2023557407 A JP2023557407 A JP 2023557407A JP 2024511057 A5 JP2024511057 A5 JP 2024511057A5
Authority
JP
Japan
Prior art keywords
depression
disorder
dystonia
disease
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023557407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511057A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/021059 external-priority patent/WO2022198116A1/en
Publication of JP2024511057A publication Critical patent/JP2024511057A/ja
Publication of JP2024511057A5 publication Critical patent/JP2024511057A5/ja
Pending legal-status Critical Current

Links

JP2023557407A 2021-03-19 2022-03-20 Kv7チャネル開口剤のプロドラッグ Pending JP2024511057A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163163470P 2021-03-19 2021-03-19
US63/163,470 2021-03-19
PCT/US2022/021059 WO2022198116A1 (en) 2021-03-19 2022-03-20 Prodrugs of kv7 channel openers

Publications (2)

Publication Number Publication Date
JP2024511057A JP2024511057A (ja) 2024-03-12
JP2024511057A5 true JP2024511057A5 (https=) 2025-02-10

Family

ID=83321210

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2023557407A Pending JP2024511057A (ja) 2021-03-19 2022-03-20 Kv7チャネル開口剤のプロドラッグ
JP2023557288A Pending JP2024511997A (ja) 2021-03-19 2022-03-20 Kv7チャネル開口剤のプロドラッグ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023557288A Pending JP2024511997A (ja) 2021-03-19 2022-03-20 Kv7チャネル開口剤のプロドラッグ

Country Status (11)

Country Link
US (3) US20240300894A1 (https=)
EP (3) EP4308545A4 (https=)
JP (2) JP2024511057A (https=)
KR (2) KR20230159506A (https=)
CN (3) CN117295711A (https=)
AU (3) AU2022240779A1 (https=)
BR (2) BR112023019074A2 (https=)
CA (3) CA3214270A1 (https=)
IL (2) IL306005A (https=)
MX (2) MX2023010976A (https=)
WO (3) WO2022198116A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117860727A (zh) * 2022-09-26 2024-04-12 江苏海洋大学 一种用于预防或治疗疼痛的药物组合物
CN118553447B (zh) * 2024-07-30 2024-11-08 四川大学华西医院 动态惊恐障碍治疗方案推荐系统、治疗系统及存储介质

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200259A1 (de) * 1992-01-08 1993-07-15 Asta Medica Ag Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung
JP2004115450A (ja) * 2002-09-27 2004-04-15 Tanabe Seiyaku Co Ltd 医薬組成物
US20060004197A1 (en) * 2004-07-02 2006-01-05 Thomas Thrash Sulfonamide-based compounds as protein tyrosine kinase inhibitors
TWI453013B (zh) * 2006-02-07 2014-09-21 Lundbeck & Co As H N-(2,4-二甲基-6-嗎啉-4-基-吡啶-3-基〉3,3-二甲基-丁醯胺之用途以及包含該化合物之醫藥品
AU2009270768A1 (en) * 2008-07-18 2010-01-21 Valeant Pharmaceuticals International Modified release formulation and methods of use
GB0813403D0 (en) * 2008-07-22 2008-08-27 Lectus Therapeutics Ltd Potassium ion channel modulators & uses thereof
CN103073455B (zh) * 2011-10-25 2015-08-19 中国科学院上海药物研究所 一类新型的kcnq钾通道激动剂、其制备方法和用途
WO2013179298A2 (en) * 2012-04-23 2013-12-05 Cadila Healthcare Limited A process for preparation of phenyl carbamate derivative and polymorphic forms thereof
US10526280B2 (en) * 2014-11-13 2020-01-07 University of Pittsburgh—of the Commonwealth System of Higher Education (2-amino-4-(arylamino)phenyl carbamates
MX2018015251A (es) * 2016-06-10 2019-04-25 Scifluor Life Sciences Inc Derivados de 2-amino-4-(amino sustituido)fenil carbamato fluorinado.
AU2019335070A1 (en) * 2018-09-06 2021-05-13 Ian Cooke Method of treating a sleep breathing disorder

Similar Documents

Publication Publication Date Title
CN101528214B (zh) 取代的n-酰基苯胺及其使用方法
JP2021105032A5 (https=)
JP2020519661A5 (https=)
JP2021519267A5 (https=)
JP2019520416A5 (https=)
JP2012503009A5 (https=)
JP2022520061A5 (https=)
JP2018505898A5 (https=)
JP2024511057A5 (https=)
JP2025504859A5 (https=)
JP2003535094A5 (https=)
JP2013545730A5 (https=)
JP2011057693A5 (https=)
JP2013501731A5 (https=)
JP2013526544A5 (https=)
JP2014502641A5 (https=)
JP2010532383A5 (https=)
JP2012255039A (ja) ニコチン性アセチルコリンα7受容体アゴニストの組合せ剤
JP2013531006A5 (https=)
JP2024511997A5 (https=)
JP2019529460A5 (https=)
JP2011505356A5 (https=)
JP2024508903A5 (https=)
JP2019520344A5 (https=)
JP2024522183A5 (https=)